Table I.
A. Standard half-life | ||||||
---|---|---|---|---|---|---|
Product brand (company) | Recombinant protein | Cell line | Fractionation | Viral inactivation | Specific activity (IU/mg of total proteins) | Comments |
Recombinate (Takeda, Tokyo, Japan) | Octocog alfa (full-length) | CHO |
|
|
>4,000 | Albumin + VWF traces |
Advate (Takeda) | Octocog alfa (full-length) | CHO |
|
|
4,000–10,000 | Protein free |
ReFacto AF ReFactoAF fuseNGO (Pfizer, New York, NY, USA) | Moroctocog alfa (B-domain deleted) | CHO |
|
|
7,600–13,800 | Protein free |
NovoEight (Novo Nordisk, Bagsværd, Denmark) | Turoctog alfa (B-domain truncated) | CHO |
|
|
8,300 | Protein free |
Nuwiq (Octapharma, Lachen, Switzerland) | Simoctocog alfa (B-domain deleted) | HEK |
|
|
9,500 | Protein free |
Kovaltry (Bayer, Leverkusen, Germany) | Octocog alfa (full-length) | BHK |
|
|
4,000 | HSP70 gene Protein free |
Afstyla (CSL Behring, King of Prussia, PA, USA) | Lonoctocog alfa (single-chain) | CHO |
|
|
16,000 | Protein free |
B. Extended half-life | ||||||
Product brand (company) | Recombinant protein | Cell line | Fractionation | Viral inactivation | Specific activity (IU/mg of total proteins) | Comments |
Elocta (Sobi, Stockholm, Sweden) | Efmoroctocg alfa (B-domain deleted) | HEK |
|
|
4,000–10,000 | IGg1 Fc-fusion protein |
Adynovi (Takeda) | Ruricotocog alfa pegol (full-length) | CHO |
|
|
4,000–6,500 | Random PEGylation 20 kDa |
Jivi (Bayer) | Damoctocog alfa pegol (B-domain deleted) | BHK |
|
|
10,000 | Site-specific PEGylation 60 kDa, branched |
Esperoct (Novo Nordisk) | Turoctocog alfa pegol (B-domain truncated) | CHO |
|
|
9,500 | Site-specific glycoPEGylation 40 kDa, branched |
Recombinant factor VIII products are listed in order of time of approval and market availability. BHK: baby hamster kidney; CHO; chinese hamster ovary; HEK: human embryonic kidney; HSP70: human shock protein 70; IgG1Fc: crystallizable fragment of immunoglobulins G1; mAb: monoclonal antibodies; TNBP: tri-n-butyl-phosphate; VWF: von Willebrand factor.